Jason Sluzevich

4PUBLICATIONS
29CO-AUTHORS
Liquid biopsiesToxicology (incl. clinical toxicology)Dental therapeutics, pharmacology and toxicologyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 27, 2026
TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris.

Alyssa Stockard, Zachary Leibovit-Reiben, Bowen Hu

|Jun 14, 2022
Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis.

Blake W Boudreaux, Thais P Pincelli, Puneet K Bhullar

|Sep 20, 2021
A Review of Oral Therapies for the Treatment of Skin Hyperpigmentation.

Serena J E Shimshak, Leila M Tolaymat, Claire B Haga

|Jul 30, 2021
Ulcerative Paraneoplastic Dermatomyositis in the Setting of Positive Transcriptional Intermediary Factor 1-γ Antibody.

Mina Z Al Awqati, Jason C Sluzevich, Florentina Berianu

Pageof 1